Viatris Announces Publication of Phase 2b CARE Study Data for Cenerimod in Lancet Rheumatology
“Biomarker data from CARE study characterizing cenerimod’s mechanism of action in systemic lupus erythematosus also published in the Annals of the Rheumatic Diseases” 🔹The publication of Phase 2b CARE study results evaluating the efficacy and safety of cenerimod in adults with moderate-to-severe systemic lupus erythematosus (SLE). 🔹The result published in Lancet rheumatology showed cenerimod 4 … Read more